This compound is a boron-containing active pharmaceutical ingredient used in pharmaceutical manufacturing. It features a complex structure with multiple functional groups including carboxylic acids and amides.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1201902-80-8
Ixazomib citrate
pharmaceutical raw material
Tofogliflozin hydrate
pharmaceutical raw material
RRT 0.81 bsp degradant
pharmaceutical raw material
Clopidogrel hydrochloride
pharmaceutical raw material
Clopidogrel bisulfate
pharmaceutical raw material
4-(carboxymethyl)-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-6-oxo-1,3,2-dioxaborinane-4-carboxylic acid
YTXSYWAKVMZICI-PVCZSOGJSA-N
B1(OC(=O)CC(O1)(CC(=O)O)C(=O)O)[C@H](CC(C)C)NC(=O)CNC(=O)C2=C(C=CC(=C2)Cl)Cl